Probiotics and prebiotics are CAM interventions frequently employed by the American public to promote intestinal health and wellness. The presence of beneficial bacteria such as lactobacilli and bifidobacteria, whether delivered exogenously as probiotics or enriched via prebiotics, has been linked to positive health effects including reduction of gut inflammation, diarrhea and allergic reactions. At present, however, our understanding of the mechanism of action underlying these biological effects is significantly lacking. Milk oligosaccharides are naturally evolved prebiotic substrates that facilitate bifidobacterial enrichment and interaction with the host. Work from the UC Davis Milk Bioactives Program has shown that human milk oligosaccharides are utilized by select bifidobacterial strains and demonstrated that small mass oligosaccharide species are uniquely consumed by Bifidobacterium longum subsp. infantis. In addition, genomic analysis of B. infantis isolates has revealed unique gene clusters linked to milk oligosaccharide metabolism that are specifically induced during growth human milk glycans but are not expressed in cells grown on lactose or current commercial prebiotics-inulin or galactooligosaccharides (GOS). There is mounting evidence to indicate that various probiotics interact with intestinal epithelial cells via the production of soluble factors shown to alter intestinal permeability and inhibit inflammatory cascades in epithelial cells. We have obtained preliminary evidence to show a probiotic species, B. infantis, produces a soluble factor(s) that activates gut enteroendocrine (EC) cells. Importantly, growth of B. infantis on milk oligosaccharides markedly increases expression of the soluble factor(s) while growth on lactose, inulin, GOS resulted in little or no production of the factor(s). In addition, growth on milk oligosaccharides also increases the ability of B. infantis to bind to intestinal epithelial cells. Thus, the presence of B. infantis with its preferred growth substrate (milk oligosaccharides) increases the probiotic binding to epithelial cells followed by release of soluble factors capable of activating EC cells. This may result in release of humoral and neuroactive mediators, to initiate changes in GI function, food intake and glucose homeostasis. The overarching aim of this proposal is to characterize the interaction of prebiotic milk oligosaccharides and bifidobacterial species in binding and activation of two types of GI epithelial cells, enterocytes and EC cells and to determine the downstream benefits of this interaction in terms of improved regulation of glucose homeostasis and body weight regulation. We will test the hypothesis that growth of probiotic B. infantis in the presence of milk oligosaccharides results in increased binding to epithelial cells and production of soluble signaling molecules that elicit activation of EC cells and release of regulatory peptides that inhibit food intake and improve glucose homeostasis. This hypothesis will be tested using the following specific aims: 1.To determine the influence of milk oligosaccharides on bifidobacterial binding to intestinal epithelial cells. 2. To determine the mechanism and functional significance of enteroendocrine cell activation by conditioned media from bifidobaceteria growth on MOS. Prebiotics and probiotics play a significant role worldwide as a CAM aimed at intestinal health and wellness. A critical barrier to progress in this field is that the mechanism by which prebiotics and probiotics influence health is ill defined. This proposal will address the role of prebiotic milk oligosaccharides as a mechanism for potentiating probiotic efficacy of B. infantis through increased binding of intestinal cells and production of a soluble signal that activates enteroendocrine cells-the latter of which collectively constitute a diffuse neuroendocrine system of the gut. The significance of this proposal is a greater mechanistic understanding of the beneficial effects of synbiotic (prebioitic plus probiotic) applications and provide clues for treatment of obesity and other disorders that involve the sensory innervation of the gut, such as functional bowel disease.

Public Health Relevance

Probiotics and prebiotics are CAM interventions frequently employed by the American public to promote intestinal health and wellness. The presence of beneficial bacteria such as lactobacilli and bifidobacteria, whether delivered exogenously as probiotics or enriched via prebiotics, has been linked to positive health effects including reduction of gut inflammation, diarrhea and allergic reactions. At present, however, our understanding of the mechanism of action underlying these biological effects is significantly lacking. The current proposal will determine the specific role of milk oligosaccharides, naturally evolved prebiotic substrates that facilitate bifidobacterial enrichment and interaction with the host, on gut epithelial cells.

Agency
National Institute of Health (NIH)
Institute
National Center for Complementary & Alternative Medicine (NCCAM)
Type
Exploratory/Developmental Grants (R21)
Project #
1R21AT006180-01A1
Application #
8191367
Study Section
Gastrointestinal Mucosal Pathobiology Study Section (GMPB)
Program Officer
Duffy, Linda C
Project Start
2011-08-01
Project End
2013-06-30
Budget Start
2011-08-01
Budget End
2012-06-30
Support Year
1
Fiscal Year
2011
Total Cost
$191,875
Indirect Cost
Name
University of California Davis
Department
Veterinary Sciences
Type
Schools of Veterinary Medicine
DUNS #
047120084
City
Davis
State
CA
Country
United States
Zip Code
95618
Sanctuary, Megan R; Kain, Jennifer N; Angkustsiri, Kathleen et al. (2018) Dietary Considerations in Autism Spectrum Disorders: The Potential Role of Protein Digestion and Microbial Putrefaction in the Gut-Brain Axis. Front Nutr 5:40
Kirmiz, Nina; Robinson, Randall C; Shah, Ishita M et al. (2018) Milk Glycans and Their Interaction with the Infant-Gut Microbiota. Annu Rev Food Sci Technol 9:429-450
Martín-Ortiz, Andrea; Barile, Daniela; Salcedo, Jaime et al. (2017) Changes in Caprine Milk Oligosaccharides at Different Lactation Stages Analyzed by High Performance Liquid Chromatography Coupled to Mass Spectrometry. J Agric Food Chem 65:3523-3531
Boudry, Gaëlle; Hamilton, M Kristina; Chichlowski, Maciej et al. (2017) Bovine milk oligosaccharides decrease gut permeability and improve inflammation and microbial dysbiosis in diet-induced obese mice. J Dairy Sci 100:2471-2481
Hamilton, M Kristina; Ronveaux, Charlotte C; Rust, Bret M et al. (2017) Prebiotic milk oligosaccharides prevent development of obese phenotype, impairment of gut permeability, and microbial dysbiosis in high fat-fed mice. Am J Physiol Gastrointest Liver Physiol 312:G474-G487
Martín-Ortiz, A; Salcedo, J; Barile, D et al. (2016) Characterization of goat colostrum oligosaccharides by nano-liquid chromatography on chip quadrupole time-of-flight mass spectrometry and hydrophilic interaction liquid chromatography-quadrupole mass spectrometry. J Chromatogr A 1428:143-53
Lee, Hyeyoung; Cuthbertson, Daniel J; Otter, Don E et al. (2016) Rapid Screening of Bovine Milk Oligosaccharides in a Whey Permeate Product and Domestic Animal Milks by Accurate Mass Database and Tandem Mass Spectral Library. J Agric Food Chem 64:6364-74
Pacheco, Alline R; Barile, Daniela; Underwood, Mark A et al. (2015) The impact of the milk glycobiome on the neonate gut microbiota. Annu Rev Anim Biosci 3:419-45
Underwood, Mark A; German, J Bruce; Lebrilla, Carlito B et al. (2015) Bifidobacterium longum subspecies infantis: champion colonizer of the infant gut. Pediatr Res 77:229-35
Karav, Sercan; Parc, Annabelle Le; de Moura Bell, Juliana Maria Leite Nobrega et al. (2015) Kinetic characterization of a novel endo-?-N-acetylglucosaminidase on concentrated bovine colostrum whey to release bioactive glycans. Enzyme Microb Technol 77:46-53

Showing the most recent 10 out of 20 publications